Oral and gut microbiome profiles in people with early idiopathic Parkinson's disease/Experiment 4

From BugSigDB


Needs review

Curated date: 2024/11/07

Curator: KateRasheed

Revision editor(s): KateRasheed

Subjects

Location of subjects
United States of America
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Parkinson disease, mitochondrial Parkinson disease, mitochondrial,parkinson disease, mitochondrial
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy Controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
Parkinson’s disease patients (PD patients)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Parkinson’s disease patients (PD patients) refers to patients with Parkinson disease - a neurodegenerative disease that is characterized by both motor symptoms, such as tremors, and non-motor symptoms, such as constipation.
Group 0 sample size Number of subjects in the control (unexposed) group
220
Group 1 sample size Number of subjects in the case (exposed) group
438
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
6 months

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Linear Regression
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
Matched on Factors on which subjects have been matched on in a case-control study
age, sex
Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
age, body mass index, smoking status, Confounders controlled for: "dessert consumption frequency" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.dessert consumption frequency, Confounders controlled for: "flossing teeth frequency" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.flossing teeth frequency, Confounders controlled for: "laxative use in the past month" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.laxative use in the past month, Confounders controlled for: "number of weekly bowel movements" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.number of weekly bowel movements, Confounders controlled for: "US census region" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.US census region

Alpha Diversity

Inverse Simpson Modification of Simpsons index D as 1/D to obtain high values in datasets of high diversity and vice versa
unchanged

Signature 1

Needs review

Curated date: 2024/11/07

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Supplementary Data 2

Description: Significant differentially abundant OTU-level microbial taxa (oral microbiota) between controls and PD cases (after adjustment for covariates) using linear models statistical test.

Abundance in Group 1: increased abundance in Parkinson’s disease patients (PD patients)

NCBI Quality ControlLinks
Actinomyces sp. oral taxon 448 str. F0400
Neisseria sp. HMSC06F02
Prevotella denticola DSM 20614 = JCM 13449
Prevotella denticola F0289
Rothia sp. HMSC064D08
Rothia sp. HMSC065D09
Selenomonas artemidis DSM 19719
Streptococcus mutans GS-5
Streptococcus mutans UA159-FR
Streptococcus sp. FDAARGOS_192
Streptococcus sp. HMSC064D12
Streptococcus sp. HMSC068F04
Streptococcus sp. HMSC072D03
Streptococcus vestibularis ATCC 49124
Fusobacterium_nucleatum_7_1Fusobacterium_nucleatum_7_1
Actinomyces_gerencseriae_DSM_6844Actinomyces_gerencseriae_DSM_6844
Streptococcus_vestibularis_22.06_S6Streptococcus_vestibularis_22.06_S6
Actinomyces_oris_R21091Actinomyces_oris_R21091
Actinomyces_oris_WE8B.23Actinomyces_oris_WE8B.23
Actinomyces_oris_CCUG_34286Actinomyces_oris_CCUG_34286
Actinomyces_oris_R11372Actinomyces_oris_R11372
Actinomyces_oris_A19A.1Actinomyces_oris_A19A.1
Actinomyces_naeslundii_NCTC_10301Actinomyces_naeslundii_NCTC_10301
Streptococcus_mutans_KCOM_1054_.._ChDC_YM3.Streptococcus_mutans_KCOM_1054_.._ChDC_YM3.

Revision editor(s): KateRasheed

Signature 2

Needs review

Curated date: 2024/11/07

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Supplementary Data 2

Description: Significant differentially abundant OTU-level microbial taxa (oral microbiota) between controls and PD cases (after adjustment for covariates) using linear models statistical test.

Abundance in Group 1: decreased abundance in Parkinson’s disease patients (PD patients)

NCBI Quality ControlLinks
Actinomyces sp. HMSC035G02
Fusobacterium periodonticum D10
Granulicatella sp. 572.rep1_STHE
Hoylesella loescheii DSM 19665 = JCM 12249 = ATCC 15930
Lachnoanaerobaculum sp. OBRC5-5
Neisseria sp. HMSC063B05
Neisseria sp. HMSC066F04
Neisseria sp. HMSC075C12
Oribacterium parvum ACB1
Rothia sp. HMSC061E04
Rothia sp. HMSC069C03
Solobacterium moorei DSM 22971
Streptococcus australis ATCC 700641
Streptococcus sp. 1171_SSPC
Streptococcus sp. 263_SSPC
Streptococcus sp. 400_SSPC
Streptococcus sp. A12
Streptococcus sp. HPH0090
Streptococcus_sp._I.P16Streptococcus_sp._I.P16
Streptococcus_sp._I.G2_I.G2Streptococcus_sp._I.G2_I.G2
Rothia_mucilaginosa_509_RMUCRothia_mucilaginosa_509_RMUC
Sanguibacter_keddieii_250_SKEDSanguibacter_keddieii_250_SKED
Streptococcus_pseudopneumoniae_1271.rep1_SPSEStreptococcus_pseudopneumoniae_1271.rep1_SPSE
Xylanimonas_cellulosilytica_352_XCELXylanimonas_cellulosilytica_352_XCEL
Streptococcus_pseudopneumoniae_469_SPSEStreptococcus_pseudopneumoniae_469_SPSE
Eikenella_corrodens_491_NMENEikenella_corrodens_491_NMEN
Actinomyces_odontolyticus_XH001Actinomyces_odontolyticus_XH001
Mogibacterium diversum CCUG 47132Mogibacterium diversum CCUG 47132

Revision editor(s): KateRasheed